Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Harbeck

Showing results (1-10 of 585) with videos related to

Pageof 59
Sort By:
MMW Fortschritte Der Medizin|May 28, 2024
[Advances in breast cancer care]Nadia Harbeck
Breast (Edinburgh, Scotland)|September 1, 2015
Insights into biology of luminal HER2 vs. enriched HER2 subtypes: Therapeutic implicationsNadia Harbeck
Nature Reviews. Disease Primers|April 25, 2020
Breast cancer is a systemic disease optimally treated by a multidisciplinary teamNadia Harbeck
Therapeutic Advances in Medical Oncology|July 24, 2018
Neoadjuvant treatment of HER2-positive breast cancer: should therapy differ based on hormone receptor status?Nadia Harbeck
Breast Cancer Research and Treatment|April 9, 2011
Struggling with subtypes: trying to bridge the gap between molecular breast cancer subtypes and clinical managementNadia Harbeck
Current Opinion in Obstetrics & Gynecology|December 2, 2017
Advances in targeting HER2-positive breast cancerNadia Harbeck
Breast Care (Basel, Switzerland)|July 19, 2019
Digitalization in Medicine: It Is Our Chance and Responsibility Now to Shape the Digital Future of Breast Cancer ManagementNadia Harbeck
Breast (Edinburgh, Scotland)|February 12, 2022
Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancerNadia Harbeck
Nature Reviews. Clinical Oncology|December 22, 2011
Breast cancer: Increasing therapy options for HER2-positive early breast cancerNadia Harbeck
Breast (Edinburgh, Scotland)|December 17, 2019
Emerging strategies in neoadjuvant treatment of patients with HER2-positive early breast cancerNadia Harbeck
Pageof 59

Showing results (1-10 of 585) with videos related to

Sort By:
Pageof 59
MMW Fortschritte Der Medizin|May 28, 2024
[Advances in breast cancer care]Nadia Harbeck
Breast (Edinburgh, Scotland)|September 1, 2015
Insights into biology of luminal HER2 vs. enriched HER2 subtypes: Therapeutic implicationsNadia Harbeck
Nature Reviews. Disease Primers|April 25, 2020
Breast cancer is a systemic disease optimally treated by a multidisciplinary teamNadia Harbeck
Therapeutic Advances in Medical Oncology|July 24, 2018
Neoadjuvant treatment of HER2-positive breast cancer: should therapy differ based on hormone receptor status?Nadia Harbeck
Breast Cancer Research and Treatment|April 9, 2011
Struggling with subtypes: trying to bridge the gap between molecular breast cancer subtypes and clinical managementNadia Harbeck
Current Opinion in Obstetrics & Gynecology|December 2, 2017
Advances in targeting HER2-positive breast cancerNadia Harbeck
Breast Care (Basel, Switzerland)|July 19, 2019
Digitalization in Medicine: It Is Our Chance and Responsibility Now to Shape the Digital Future of Breast Cancer ManagementNadia Harbeck
Breast (Edinburgh, Scotland)|February 12, 2022
Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancerNadia Harbeck
Nature Reviews. Clinical Oncology|December 22, 2011
Breast cancer: Increasing therapy options for HER2-positive early breast cancerNadia Harbeck
Breast (Edinburgh, Scotland)|December 17, 2019
Emerging strategies in neoadjuvant treatment of patients with HER2-positive early breast cancerNadia Harbeck
Pageof 59